MedPath

Imaging of High Grade Prostate Cancer

Not Applicable
Terminated
Conditions
Prostatic Carcinoma
Registration Number
NCT02177526
Lead Sponsor
Ottawa Hospital Research Institute
Brief Summary

Management of prostatic carcinoma varies according to stage of disease. Trans-rectal ultrasound guided biopsy is known to underestimate the degree of tumor due to undersampling and random non-targeted technique. Methods to improve pre-operative tumor localization and grading, including multi-parametric (MP) magnetic resonance imaging (MRI) is an active area of research but requires further validation.

High grade tumors can undergo comedo-type necrosis with malignant calcifications which only occurs in Gleason pattern 5 tumors and which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI.

Detection of malignant calcification within tumor foci will improve the accuracy of localization and grading in prostatic carcinoma.

Detailed Description

High grade (Gleason pattern 5) tumors can undergo comedo-type necrosis producing malignant calcifications which we hypothesize can be reliably detected using computed tomography (CT) and/or MRI. Detection of malignant calcifications in areas of Gleason pattern 5 tumor will improve the accuracy of pre-operative localization and grading in prostatic carcinoma.

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Patients with malignant comedo-type necrosis and calcifications detected with histo-pathology from guided biopsies
  • Patients with biopsy proven Gleason pattern 5 tumor and without comedo-type necrosis associated calcification
Exclusion Criteria
  • Patients who do not have malignant comedo-type necrosis and calcifications detected with histo-pathology from guided biopsies

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
The number of prostate patients with comedo-type necrosis.up to 4 weeks

Two radiologists will review the MRI and CT examinations separated by a 4 week interval to decrease recall bias. Further, readers will review the 3 additional gradient echo pulse sequences independently at 3 different MRI reading sessions, also separated by 4 weeks, in order to compare the accuracy from each pulse sequence and to reduce recall bias.

Secondary Outcome Measures
NameTimeMethod
The number of other features measured on MRI.up to 4 weeks

Two radiologists will review the MRI and CT examinations separated by a 4 week interval to compare other MRI features and clinical factors between Gleason pattern 5 tumors with and without malignant calcification.

Trial Locations

Locations (1)

Ottawa Hospital (Civic Campus)

🇨🇦

Ottawa, Ontario, Canada

Ottawa Hospital (Civic Campus)
🇨🇦Ottawa, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.